RecruitingNot Applicable

Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection

Germany500 participantsStarted 2024-03-13

Plain-language summary

The aim is rapid collection of real-life data on the epidemiology, treatment and disease course in patients with VEXAS syndrome during routine clinical practice and collect biomaterials to evaluate genotype-phenotype associations, determine optimal treatment schedule, identify diagnostic features and biomarkers

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with established or suspected (clinical and hematological criteria) VEXAS Syndrome * Age ≥18 years * Signed informed consent form Exclusion Criteria: * patients who are not in a position to understand the nature and scope of participation in this register

What they're measuring

Collection of epidemiological data on VEXAS

Timeframe: enrollment

Collection and monitoring of initial disease manifestations

Timeframe: 5 years

Documentation of the treatment approaches and therapy sequences

Timeframe: 5 years

Analysis of clinical-relevant clinical endpoints

Timeframe: 5 years

Trial details

NCT IDNCT06377462

SponsorTechnische Universität Dresden

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2029-12-31

Contact for this trial

Katja Sockel, Dr. med.

+493514585627 katja.sockel@ukdd.de

View on ClinicalTrials.gov More VEXAS Syndrome trials